PSPH
Phosphoserine phosphatase
Also known as: PSP, SERB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P78330
- Gene
- PSPH
- Ensembl
- ENSG00000146733
- Chromosome
- 7
- Canonical length
- 225 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene belongs to a subfamily of the phosphotransferases. This encoded enzyme is responsible for the third and last step in L-serine formation. It catalyzes magnesium-dependent hydrolysis of L-phosphoserine and is also involved in an exchange reaction between L-serine and L-phosphoserine. Deficiency of this protein is thought to be linked to Williams syndrome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
225 residues, UniProt reviewed canonical sequence.
>P78330|PSPH
1 MVSHSELRKL FYSADAVCFD VDSTVIREEG IDELAKICGV EDAVSEMTRR AMGGAVPFKA
61 ALTERLALIQ PSREQVQRLI AEQPPHLTPG IRELVSRLQE RNVQVFLISG GFRSIVEHVA
121 SKLNIPATNV FANRLKFYFN GEYAGFDETQ PTAESGGKGK VIKLLKEKFH FKKIIMIGDG
181 ATDMEACPPA DAFIGFGGNV IRQQVKDNAK WYITDFVELL GELEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PSPH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 16 nTPM
- choroid plexus: 13 nTPM
- basal ganglia: 12 nTPM
- spinal cord: 12 nTPM
- kidney: 11 nTPM
- amygdala: 11 nTPM
Single-cell type
- late spermatids: 157 nCPM
- early spermatids: 138 nCPM
- endometrial ciliated cells: 72 nCPM
- müller glia: 60 nCPM
- late primary spermatocytes: 54 nCPM
- fallopian tube ciliated cells: 48 nCPM
Immune cell
- myeloid DC: 9.8 nTPM
- plasmacytoid DC: 9.5 nTPM
- non-classical monocyte: 7.3 nTPM
- classical monocyte: 6.6 nTPM
- eosinophil: 6.3 nTPM
- naive B-cell: 6.3 nTPM
Brain region
- white matter: 29 nTPM
- choroid plexus: 26 nTPM
- midbrain: 25 nTPM
- medulla oblongata: 23 nTPM
- spinal cord: 23 nTPM
- basal ganglia: 23 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PSPH.
Disease | AllUniProt
Conditions PSPH is implicated in, by any mechanism.
- Phosphoserine phosphatase deficiency (PSPHD) MIM:614023
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 196 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Deficiency of phosphoserine phosphatase
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.78
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- in utero embryonic development
- L-serine biosynthetic process
- L-serine metabolic process
- response to mechanical stimulus
- response to nutrient levels
- response to testosterone
Molecular functions
- identical protein binding
- magnesium ion binding
- protein homodimerization activity
- L-phosphoserine phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- HAD superfamily
- HAD-like superfamily
- haloacid dehalogenase-like hydrolase
- Phosphoserine phosphatase
- HAD-like hydrolase superfamily, SerB
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PSPH as an antibody target. Whether an autoantibody or antibody against PSPH could matter depends on whether native PSPH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PSPH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PSPH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...